Nanoparticle transport across in vitro olfactory cell monolayers.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  International journal of pharmaceutics

• Publication date

  2016-02-29

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.ijpharm.2015.12.046PMID 26721725
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Particulate formulations based on chitosan for nose-to-brain delivery of drugs. A review

  2016cited by this paper
• Nanostructured lipid carriers: Promising drug delivery systems for future clinics.

  2016cited by this paper
• Curcumin-loaded nanostructured lipid carriers (NLCs) for nasal administration: design, characterization, and in vivo study

  2016cited by this paper
• Brain delivery of intranasal in situ gel of nanoparticulated polymeric carriers containing antidepressant drug: behavioral and biochemical assessment

  2015cited by this paper
• Chitosan coated nanostructured lipid carriers for brain delivery of proteins by intranasal administration.

  2015influential reference
• Tailored polymer-lipid hybrid nanoparticles for the delivery of drug conjugate: dual strategy for brain targeting.

  2015cited by this paper
• Brain delivery of insulin boosted by intranasal coadministration with cell-penetrating peptides.

  2015cited by this paper
• Lactoferrin- and antitransferrin-modified liposomes for brain targeting of the NK3 receptor agonist senktide: preparation and in vivo evaluation.

  2015cited by this paper
• Nose-To-Brain Delivery of PLGA-Diazepam Nanoparticles

  2015cited by this paper
• Optoacoustic imaging enabled biodistribution study of cationic polymeric biodegradable nanoparticles.

  2015influential reference
• Development of surface modified biodegradable polymeric nanoparticles to deliver GSE24.2 peptide to cells: a promising approach for the treatment of defective telomerase disorders.

  2015influential reference
• Nose-to-Brain Delivery: Investigation of the Transport of Nanoparticles with Different Surface Characteristics and Sizes in Excised Porcine Olfactory Epithelium.

  2015cited by this paper
• The effects of human serum to the morphology, proliferation and gene expression level of the respiratory epithelium in vitro.

  2014cited by this paper
• Dextran-protamine coated nanostructured lipid carriers as mucus-penetrating nanoparticles for lipophilic drugs.

  2014influential reference
• The blood-brain barrier: Structure, function and therapeutic approaches to cross it

  2014cited by this paper
• Surface engineered nanostructured lipid carriers for efficient nose to brain delivery of ondansetron HCl using Delonix regia gum as a natural mucoadhesive polymer.

  2014cited by this paper
• Nanotoxicology applied to solid lipid nanoparticles and nanostructured lipid carriers - a systematic review of in vitro data.

  2014cited by this paper
• Intranasal nanoparticles of basic fibroblast growth factor for brain delivery to treat Alzheimer's disease.

  2014cited by this paper
• Formulation and Optimization of Polymeric Nanoparticles for Intranasal Delivery of Lorazepam Using Box-Behnken Design: In Vitro and In Vivo Evaluation

  2014cited by this paper
• Solid lipid nanoparticles for nose to brain delivery of haloperidol: in vitro drug release and pharmacokinetics evaluation

  2014cited by this paper
• Nose-to-brain delivery: evaluation of polymeric nanoparticles on olfactory ensheathing cells uptake.

  2014cited by this paper
• Pharmacoscintigraphic evaluation of potential of lipid nanocarriers for nose-to-brain delivery of antidepressant drug.

  2014cited by this paper
• Hydrophilic coating of mitotane-loaded lipid nanoparticles: Preliminary studies for mucosal adhesion

  2013cited by this paper
• Mechanism of transport of saquinavir-loaded nanostructured lipid carriers across the intestinal barrier.

  2013influential reference
• Cell penetrating peptide conjugated polymeric micelles as a high performance versatile nonviral gene carrier.

  2013cited by this paper
• Bromocriptine loaded chitosan nanoparticles intended for direct nose to brain delivery: pharmacodynamic, pharmacokinetic and scintigraphy study in mice model.

  2013cited by this paper
• Improvement of drug safety by the use of lipid-based nanocarriers.

  2012cited by this paper
• Brain targeting of risperidone-loaded solid lipid nanoparticles by intranasal route

  2011cited by this paper
• Development of peptide and protein nanotherapeutics by nanoencapsulation and nanobioconjugation.

  2011cited by this paper
• Cell-Penetrating Peptide-Modified Block Copolymer Micelles Promote Direct Brain Delivery via Intranasal Administration

  2011cited by this paper
• Development and evaluation of olanzapine-loaded PLGA nanoparticles for nose-to-brain delivery: in vitro and in vivo studies.

  2011cited by this paper
• Cell-Penetrating Peptides—Mechanisms of Cellular Uptake and Generation of Delivery Systems

  2010cited by this paper
• A comparative study of chitosan and chitosan/cyclodextrin nanoparticles as potential carriers for the oral delivery of small peptides.

  2010cited by this paper
• Nanoparticles for direct nose-to-brain delivery of drugs.

  2009cited by this paper
• stablishing a physiological environment for visualized in vitro brain slice ecordings by increasing oxygen supply and modifying aCSF content

  2009influential reference
• From nose to brain: understanding transport capacity and transport rate of drugs

  2008cited by this paper
• Transport mechanisms of mmePEG750P(CL-co-TMC) polymeric micelles across the intestinal barrier.

  2007influential reference
• Intranasal delivery: physicochemical and therapeutic aspects.

  2007cited by this paper
• An improved in vitro model of human intestinal follicle-associated epithelium to study nanoparticle transport by M cells.

  2007influential reference
• PEGylated PLGA-based nanoparticles targeting M cells for oral vaccination.

  2007cited by this paper
• Cell-penetrating peptides: mechanism and kinetics of cargo delivery.

  2005influential reference
• Transport of nanoparticles across an in vitro model of the human intestinal follicle associated epithelium.

  2005influential reference
• Intranasal drug delivery for brain targeting.

  2005cited by this paper
• Neurotrophin 3 promotes purification and proliferation of olfactory ensheathing cells from human nose

  2004influential reference
• Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.

  2004cited by this paper
• Studies on the Internalization Mechanism of Cationic Cell-penetrating Peptides*

  2003cited by this paper
• Comparative Uptake Studies of Bioadhesive and Non-Bioadhesive Nanoparticles in Human Intestinal Cell Lines and Rats: The Effect of Mucus on Particle Adsorption and Transport

  2002cited by this paper
• Transport of drugs from the nasal cavity to the central nervous system.

  2000influential reference
• Expression of specific markers and particle transport in a new human intestinal M-cell model.

  2000cited by this paper
• Effect of chitosan on epithelial permeability and structure.

  1999cited by this paper
• Editorial from the president of the EUFEPS

  1993cited by this paper

• Comparative study of transdermal and intranasal delivery of escitalopram/SPIONs-loaded transinvasomes: A magnetoresponsive nanocarrier for enhanced brain targeting in glioblastoma multiforme therapy

  2026cites this paper
• Overcoming translational barriers in nose-to-brain drug delivery for clinical applications.

  2026cites this paper
• Efficient nose-to-brain delivery of nine residues peptide (JAL-TA9) exhibiting hydrolytic activity against amyloid-β.

  2025cites this paper
• The Application of Polymeric Nanoparticles as Drug Delivery Carriers to Cells in Neurodegenerative Diseases

  2025cites this paper
• Nose-to-brain drug delivery: from bench to bedside

  2025cites this paper
• Polymeric Nanocarrier-Based Drug Formulations for Enhancing Nose-to-Brain Delivery

  2025cites this paper
• Polymeric nanoparticles for efficient nose-to-brain delivery.

  2025cites this paper
• Optimized Lacosamide Nanostructured Lipid Carriers for Enhanced Brain Targeting Via the Intranasal Route

  2025cites this paper
• A Cell-Based Nasal Model for Screening the Deposition, Biocompatibility, and Transport of Aerosolized PLGA Nanoparticles

  2024cites this paper
• Biomaterials Comprising Implantable and Dermal Drug Delivery Targeting Brain in Management of Alzheimer’s Disease: A Review

  2024cites this paper
• Advances in Polysaccharide-Based Formulations for Intranasal Drug Delivery: A Review

  2024cites this paper
• Preparation, physicochemical characterization, ex vivo, and in vivo evaluations of asiatic acid-loaded solid lipid nanoparticles formulated with natural waxes for nose-to-brain delivery.

  2024cites this paper
• Air Pollution as an Environmental Risk Factor for Alzheimer’s Disease and Related Dementias

  2024cites this paper
• Exploring the Potential of Nasal Drug Delivery for Brain Targeted Therapy: A Detailed Analysis

  2024cites this paper
• Insight into central nervous system targeted nanostructured lipid carriers via the nose to brain pathway

  2024cites this paper
• NANOPARTÍCULAS POLIMÉRICAS PARA ENTREGA DE FÁRMACOS AO CÉREBRO POR ADMINISTRAÇÃO INTRANASAL: UMA BREVE REVISÃO

  2024cites this paper
• Functionalized nanoparticles to deliver nucleic acids to the brain for the treatment of Alzheimer’s disease

  2024cites this paper
• Breaking barriers: Intranasal delivery of brexpiprazole-nanostructured lipid carriers targets the brain for effective schizophrenia treatment

  2023cites this paper
• Effect of mucociliary clearance on the particulate airflow inside the nasal sinus and its role in increasing the residence time and absorption of drugs inside the upper respiratory pathway

  2023cites this paper
• Age features of the correction of alcohol motivation and voluntary alcohol consumption by intranasal administration of dehydroepiandrosterone under long-term preventive alcoholization (experimental study)

  2023cites this paper
• New advances in diagnosis and treatment of nano drug delivery systems across the blood-brain barrier

  2023influential citation
• Computational, In Vitro, and In Vivo Models for Nose-to-Brain Drug Delivery Studies

  2023cites this paper
• Intranasal administration of olanzapine has beneficial outcome in a rat activity-based anorexia model.

  2023cites this paper
• Investigating the Targeting Power to Brain Tissues of Intranasal Rasagiline Mesylate-Loaded Transferosomal In Situ Gel for Efficient Treatment of Parkinson’s Disease

  2023cites this paper
• Nanocarrier facilitated drug delivery to the brain through intranasal route: A promising approach to transcend bio-obstacles and alleviate neurodegenerative conditions

  2022cites this paper
• Targeting Fibronectin to Overcome Remyelination Failure in Multiple Sclerosis: The Need for Brain- and Lesion-Targeted Drug Delivery

  2022cites this paper
• Nanocarrier-Based Drug Delivery to Brain: Interventions of Surface Modification

  2022cites this paper
• Dual effect of TAT functionalized DHAH lipid nanoparticles with neurotrophic factors in human BBB and microglia cultures

  2022influential citation
• In Vitro Evaluation of Curcumin- and Quercetin-Loaded Nanoemulsions for Intranasal Administration: Effect of Surface Charge and Viscosity

  2022cites this paper
• Correction of the wake-sleep cycle by intranasal administration of dopamine in modeling of the preclinical stage of Parkinson's disease in rats

  2022cites this paper
• Lipid nanocapsules for the nose-to-brain delivery of the anti-inflammatory bioactive lipid PGD2-G.

  2022cites this paper
• Brain targeted delivery of carmustine using chitosan coated nanoparticles via nasal route for glioblastoma treatment.

  2022cites this paper
• Biopolymer Nanoparticles for Nose-to-Brain Drug Delivery: A New Promising Approach for the Treatment of Neurological Diseases

  2022cites this paper
• Multiple Roles of Chitosan in Mucosal Drug Delivery: An Updated Review

  2022cites this paper
• Design and optimization of curcumin loaded nano lipid carrier system using Box-Behnken design.

  2021cites this paper
• Nanomedicines for Brain Drug Delivery

  2021cites this paper
• A comparison study of Lipid and Polymeric Nanoparticles in the Nasal Delivery of Meloxicam: Formulation, Characterization, and In-Vitro Evaluation.

  2021cites this paper
• Microemulsion as a promising carrier for nose to brain delivery: journey since last decade

  2021cites this paper
• New Insights into Nanoparticulate Carriers for Direct Nose‐to‐Brain Drug Delivery

  2021cites this paper
• Direct nose to the brain nanomedicine delivery presents a formidable challenge.

  2021cites this paper
• Convolutions in the rendition of nose to brain therapeutics from bench to bedside: Feats & fallacies.

  2021cites this paper
• Comparative evaluation of intranasally delivered quetiapine loaded mucoadhesive microemulsion and polymeric nanoparticles for brain targeting: pharmacokinetic and gamma scintigraphy studies

  2021cites this paper
• Intranasal Drug Delivery: Novel Delivery Route for Management of Parkinson’s and Depression Neurological Disorders

  2021cites this paper
• Core-shell lipoplexes inducing active macropinocytosis promote intranasal delivery of c-Myc siRNA for treatment of glioblastoma.

  2021cites this paper
• Direct Delivery of ANA-TA9, a Peptide Capable of Aβ Hydrolysis, to the Brain by Intranasal Administration

  2021cites this paper
• Regenerative nanomedicine applications for neurodegenerative diseases of central nervous system

  2021cites this paper
• Engineered exosomes: desirable target-tracking characteristics for cerebrovascular and neurodegenerative disease therapies

  2021cites this paper
• Intranasal drug delivery for treatment of Alzheimer’s disease

  2021cites this paper
• Nose-to-Brain Drug Delivery Enabled by Nanocarriers

  2020cites this paper
• Current insights on lipid nanocarrier-assisted drug delivery in the treatment of neurodegenerative diseases.

  2020cites this paper
• Nasal administration of nanoencapsulated geraniol/ursodeoxycholic acid conjugate: Towards a new approach for the management of Parkinson's disease.

  2020cites this paper
• Nasal delivery nanoparticles

  2020cites this paper
• Chitosan-based nanomedicine for brain delivery: Where are we heading?

  2020cites this paper
• Coated Lipidic Nanoparticles as a New Strategy for Enhancing Nose-to-Brain Delivery of a Hydrophilic Drug Molecule.

  2020cites this paper
• Carbohydrate polymer-based nanoparticle application in drug delivery for CNS-related disorders

  2020cites this paper
• A Reevaluation of Chitosan-Decorated Nanoparticles to Cross the Blood-Brain Barrier

  2020cites this paper
• Nanostructured Lipid Carriers Made of Ω-3 Polyunsaturated Fatty Acids: In Vitro Evaluation of Emerging Nanocarriers to Treat Neurodegenerative Diseases

  2020influential citation
• Bigger or Smaller? Size and Loading Effects on Nanoparticle Uptake Efficiency in the Nasal Mucosa

  2020cites this paper
• Nose to brain delivery of eletriptan hydrobromide nanoparticles: Preparation, in vitro/in vivo evaluation and effect on trigeminal activation

  2020cites this paper
• Patient-Friendly, Olfactory-Targeted, Stimuli-Responsive Hydrogels for Cerebral Degenerative Disorders Ensured > 400% Brain Targeting Efficiency in Rats

  2020cites this paper
• Nose to brain delivery of antiretroviral drugs in the treatment of neuroAIDS

  2020cites this paper
• In vivo biodistribution of venlafaxine-PLGA nanoparticles for brain delivery: plain vs. functionalized nanoparticles

  2019cites this paper
• Nanoscopic Structure of Complexes Formed Between DNA and the Cell Penetrating Peptide Penetratin.

  2019cites this paper
• Increased Nose-to-Brain Delivery of Melatonin Mediated by Polycaprolactone Nanoparticles for the Treatment of Glioblastoma

  2019cites this paper
• Surface-Functionalized Lipid Nanoparticles for Site-Specific Drug Delivery

  2019cites this paper
• Successful Delivery of Zidovudine-Loaded Docosanol Nanostructured Lipid Carriers (Docosanol NLCs) into Rat Brain

  2019cites this paper
• Surface-Modified PLGA Nanoparticles for Targeted Drug Delivery to Neurons

  2019cites this paper
• In-vitro and in-vivo Characterization of a Multi-Stage Enzyme-Responsive Nanoparticle-in-Microgel Pulmonary Drug Delivery System

  2019cites this paper
• Surface Modification of Nanoparticles for Targeted Drug Delivery

  2019cites this paper
• How to characterize a nasal product. The state of the art of in vitro and ex vivo specific methods

  2019cites this paper
• Micro- and nanotechnology approaches to improve Parkinson's disease therapy.

  2019cites this paper
• Formulation and Evaluation of Eudragit RL-100 Nanoparticles Loaded In-Situ Forming Gel for Intranasal Delivery of Rivastigmine

  2019cites this paper
• Comparison of bulk and microfluidics methods for the formulation of poly-lactic-co-glycolic acid (PLGA) nanoparticles modified with cell-penetrating peptides of different architectures

  2019cites this paper
• Intranasal Nanoparticulate Systems as Alternative Route of Drug Delivery.

  2019cites this paper
• Nose to Brain Drug Delivery: A Recent Update

  2018cites this paper
• 1 Surface-modified nanocarriers for nose-to-brain 2 delivery : from bioadhesion to targeting 3

  2018cites this paper
• Recent advances in carrier mediated nose‐to‐brain delivery of pharmaceutics

  2018cites this paper
• The stimulation of GLP-1 secretion and delivery of GLP-1 agonists via nanostructured lipid carriers.

  2018cites this paper
• Peptide Mediated Brain Delivery of Nano- and Submicroparticles: A Synergistic 
Approach

  2018cites this paper
• Surface-Modified Nanocarriers for Nose-to-Brain Delivery: From Bioadhesion to Targeting

  2018cites this paper
• Evaluation of intranasal delivery route of drug administration for brain targeting.

  2018cites this paper
• Allogenic Fc Domain-Facilitated Uptake of IgG in Nasal Lamina Propria: Friend or Foe for Intranasal CNS Delivery?

  2018cites this paper
• An update on the role of nanovehicles in nose-to-brain drug delivery.

  2018cites this paper
• Intranasal Administration of TAT-Conjugated Lipid Nanocarriers Loading GDNF for Parkinson’s Disease

  2017cites this paper
• Nanotechnology Based Approaches for Neurodegenerative Disorders: Diagnosis and Treatment

  2017cites this paper
• Nose-to-brain delivery of BACE1 siRNA loaded in solid lipid nanoparticles for Alzheimer's therapy.

  2017cites this paper
• Lipid Nanoparticles for Nasal/Intranasal Drug Delivery.

  2017cites this paper
• Nose-to-brain peptide delivery - The potential of nanotechnology.

  2017cites this paper
• Application of RPMI 2650 as a cell model to evaluate solid formulations for intranasal delivery of drugs.

  2016cites this paper
• Intranasal Administration of chitosan-Coated Nanostructured Lipid Carriers Loaded with GDNF Improves Behavioral and Histological Recovery in a Partial Lesion Model of Parkinson's Disease.

  2016cites this paper
• A Mechanistic Study on Nanoparticle-Mediated Glucagon-Like Peptide-1 (GLP-1) Secretion from Enteroendocrine L Cells.

  2016cites this paper
• Penetratin Peptide-Functionalized Gold Nanostars: Enhanced BBB Permeability and NIR Photothermal Treatment of Alzheimer's Disease Using Ultralow Irradiance.

  2016cites this paper
• NFL-lipid nanocapsules for brain neural stem cell targeting in vitro and in vivo.

  2016cites this paper